CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $82.54 billion. The enterprise value is $83.95 billion.
Market Cap | 82.54B |
Enterprise Value | 83.95B |
Important Dates
The last earnings date was Wednesday, October 23, 2024, before market open.
Earnings Date | Oct 23, 2024 |
Ex-Dividend Date | Sep 9, 2024 |
Share Statistics
CME Group has 360.36 million shares outstanding. The number of shares has increased by 0.13% in one year.
Current Share Class | 360.36M |
Shares Outstanding | 360.36M |
Shares Change (YoY) | +0.13% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 0.33% |
Owned by Institutions (%) | 89.92% |
Float | 358.80M |
Valuation Ratios
The trailing PE ratio is 24.08 and the forward PE ratio is 22.40. CME Group's PEG ratio is 5.28.
PE Ratio | 24.08 |
Forward PE | 22.40 |
PS Ratio | 13.64 |
Forward PS | 13.62 |
PB Ratio | 2.92 |
P/TBV Ratio | n/a |
P/FCF Ratio | 22.75 |
P/OCF Ratio | 22.21 |
PEG Ratio | 5.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.94, with an EV/FCF ratio of 23.14.
EV / Earnings | 24.53 |
EV / Sales | 13.91 |
EV / EBITDA | 19.94 |
EV / EBIT | 21.69 |
EV / FCF | 23.14 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
Current Ratio | 1.02 |
Quick Ratio | 0.03 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.90 |
Debt / FCF | 1.06 |
Interest Coverage | 24.20 |
Financial Efficiency
Return on equity (ROE) is 12.30% and return on invested capital (ROIC) is 7.55%.
Return on Equity (ROE) | 12.30% |
Return on Assets (ROA) | 1.84% |
Return on Capital (ROIC) | 7.55% |
Revenue Per Employee | $1.69M |
Profits Per Employee | $959,916 |
Employee Count | 3,565 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $985.00 million in taxes.
Income Tax | 985.00M |
Effective Tax Rate | 22.13% |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks. The beta is 0.56, so CME Group's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | +6.25% |
50-Day Moving Average | 223.63 |
200-Day Moving Average | 211.94 |
Relative Strength Index (RSI) | 57.21 |
Average Volume (20 Days) | 1,780,755 |
Short Selling Information
The latest short interest is 3.83 million, so 1.06% of the outstanding shares have been sold short.
Short Interest | 3.83M |
Short Previous Month | 3.63M |
Short % of Shares Out | 1.06% |
Short % of Float | 1.07% |
Short Ratio (days to cover) | 2.39 |
Income Statement
In the last 12 months, CME Group had revenue of $6.03 billion and earned $3.42 billion in profits. Earnings per share was $9.51.
Revenue | 6.03B |
Gross Profit | 6.03B |
Operating Income | 3.87B |
Pretax Income | 4.25B |
Net Income | 3.42B |
EBITDA | 4.21B |
EBIT | 3.87B |
Earnings Per Share (EPS) | $9.51 |
Balance Sheet
The company has $2.43 billion in cash and $3.84 billion in debt, giving a net cash position of -$1.41 billion or -$3.91 per share.
Cash & Cash Equivalents | 2.43B |
Total Debt | 3.84B |
Net Cash | -1.41B |
Net Cash Per Share | -$3.91 |
Equity (Book Value) | 28.22B |
Book Value Per Share | 78.47 |
Working Capital | 2.32B |
Cash Flow
In the last 12 months, operating cash flow was $3.72 billion and capital expenditures -$88.60 million, giving a free cash flow of $3.63 billion.
Operating Cash Flow | 3.72B |
Capital Expenditures | -88.60M |
Free Cash Flow | 3.63B |
FCF Per Share | $10.07 |
Margins
Gross margin is 100.00%, with operating and profit margins of 64.14% and 57.43%.
Gross Margin | 100.00% |
Operating Margin | 64.14% |
Pretax Margin | 73.76% |
Profit Margin | 57.43% |
EBITDA Margin | 69.77% |
EBIT Margin | 64.14% |
FCF Margin | 60.23% |
Dividends & Yields
This stock pays an annual dividend of $4.60, which amounts to a dividend yield of 2.01%.
Dividend Per Share | $4.60 |
Dividend Yield | 2.01% |
Dividend Growth (YoY) | 5.81% |
Years of Dividend Growth | 13 |
Payout Ratio | 48.37% |
Buyback Yield | -0.13% |
Shareholder Yield | 1.88% |
Earnings Yield | 4.15% |
FCF Yield | 4.40% |
Analyst Forecast
The average price target for CME Group is $225.13, which is -1.71% lower than the current price. The consensus rating is "Hold".
Price Target | $225.13 |
Price Target Difference | -1.71% |
Analyst Consensus | Hold |
Analyst Count | 16 |
Revenue Growth Forecast (5Y) | 4.38% |
EPS Growth Forecast (5Y) | 5.29% |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
Last Split Date | Jul 23, 2012 |
Split Type | Forward |
Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.63 |
Piotroski F-Score | 6 |